The propensity score-matched longitudinal study aimed to compare the efficacy of generic and brand-name formulations of levothyroxine in achieving and maintaining target thyrotropin levels. For ...

Patients diagnosed with hypothyroidism (almost all with benign disease) who were prescribed levothyroxine (L-T4) had similar rates of short-term cardiovascular events whether they received a branded ...

Lupin has received the Food and Drug Administration’s nod for a new indication for levothyroxine sodium tablets. The product now is approved as a generic of King Pharmaceutical’s Levoxyl in dosage ...

MAHA-aligned patients and providers are pushing back to ensure access to an animal-derived thyroid hormone treatment.

New York (MedscapeWire) Aug 8 — Abbott Laboratories has submitted a New Drug Application (NDA) for levothyroxine sodium (Synthroid) to the US Food and Drug Administration (FDA), in advance of the ...